Pregnant women and novel influenza A (H1N1): considerations for clinicians. Centers for Disease Control and Prevention. NGC:007261
- Publication Details
-
- Author(s):
-
- AHRQ (US) - Agency for Healthcare Research and Quality
- Country(ies) of application:
-
- United States
- Language(s):
-
- English
- Type of Publication:
- Guideline Clearing Report
- Publication URL:
- Open Publication URL in a new window
- Publication Scope:
-
- Prevention
- Management
- Publication Status:
- Published
- Date of publication:
- May 21, 2009
- Due for Review:
- -
- Diseases / Conditions Addressed
-
- MeSH Terms addressed:
-
-
Respiratory Tract Diseases (C08)
- Respiratory Tract Infections (C08.730)
-
Sexually Transmitted Diseases (C01.539.780 / C02.800)
-
Sexually Transmitted Diseases, Viral (C02.800.801)
- HIV Infections (C02.800.801.400)
-
Sexually Transmitted Diseases, Viral (C02.800.801)
-
Immune System Disorders / Immunologic Diseases (C20)
-
Immunologic Deficiency Syndromes (C20.673)
- HIV Infections (C20.673.480)
-
Immunologic Deficiency Syndromes (C20.673)
-
Female Genital Diseases and Pregnancy Complications (C13)
- Pregnancy Complications (C13.703)
-
Reproduction (G08.520)
- Pregnancy (G08.520.769)
-
Virus Infections (C02)
-
RNA Virus Infections (C02.782)
- Influenza, Human (C02.782.620.365)
- HIV Infections (C02.782.815.616.400)
-
RNA Virus Infections (C02.782)
-
Respiratory Tract Diseases (C08)
- Guideline key questions






